Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Finasteride and dutasteride may help prevent hair loss but could cause side effects like sexual dysfunction and psychological issues.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

Rats had lasting erectile problems after stopping a certain medication.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Formononetin, found in red clover, may treat hair loss with fewer side effects.

Finasteride and minoxidil mix works better for hair growth than minoxidil alone, with similar safety.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Finasteride use in young men with hair loss is linked to sexual dysfunction.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Various treatments exist for hair loss, but more research is needed for better options.

LLLT is a safe, promising hair loss treatment, but more research needed.